Dr. Stern is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
58 Orchard Hill Rd
Katonah, NY 10536Phone+1 203-232-7896
Education & Training
- NYU Grossman School of MedicineFellowship, Gastroenterology, 1980 - 1982
- NYU Grossman School of MedicineResidency, Internal Medicine, 1977 - 1980
- Albert Einstein College of MedicineClass of 1977
Certifications & Licensure
- NY State Medical License 1978 - 2026
- CT State Medical License 1996 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Open‐label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1‐infected patients who failed placebo plus peginterferon and ribavirinGraham R. Foster, Peter Ferenci, Tarik Asselah, Parvez S. Mantry, Jean-François Dufour
Journal of Viral Hepatitis. 2016-03-01 - 5 citationsITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.Tarik Asselah, Stefan Zeuzem, Vicente Soriano, Jean-Pierre Bronowicki, Ansgar W. Lohse
Plos One. 2015-12-09 - 18 citationsSTARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionPeter Ferenci, Tarik Asselah, Graham R. Foster, Stefan Zeuzem, Christoph Sarrazin
Journal of Hepatology. 2015-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: